NasdaqCM:CLDXBiotechs
A Look At Celldex Therapeutics (CLDX) Valuation After Recent Share Price Weakness
CLDX stock reaction and recent performance
Celldex Therapeutics (CLDX) has been moving without a clear single news catalyst. This puts the focus on how the stock has behaved recently and what its fundamentals look like today.
Over the past month the share price has recorded a 3.4% decline, while the past 3 months show a 3% decline. Year to date, CLDX is down about 4%, although the 1 year total return stands at 7.9%.
See our latest analysis for Celldex Therapeutics.
At a share price of...